• Ying Tan, Sainan Chen, Jiankai Zhong, Jun Ren, and Maolong Dong.
• Department of Emergency Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
• Curr. Pharm. Des. 2019 Jan 1; 25 (18): 2060-2070.

BackgroundSepsis and septic shock are known to prompt multiple organ failure including cardiac contractile dysfunction, which is typically referred to as septic cardiomyopathy. Among various theories postulated for the etiology of septic cardiomyopathy, mitochondrial injury (both morphology and function) in the heart is perceived as the main culprit for reduced myocardial performance and ultimately heart failure in the face of sepsis.MethodsOver the past decades, ample of experimental and clinical work have appeared, focusing on myocardial mitochondrial changes and related interventions in septic cardiomyopathy.Results And ConclusionHere we will briefly summarize the recent experimental and clinical progress on myocardial mitochondrial morphology and function in sepsis, and discuss possible underlying mechanisms, as well as the contemporary interventional options.Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

17 keywords...

hide…